Cargando…
Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus
In the normal immune system, T cell activation is tightly regulated and controlled at several levels to ensure that activation occurs in the right context to prevent the development of pathologic conditions such as autoimmunity or other harmful immune responses. CD4(+)FoxP3(+) regulatory T cells (Tr...
Autores principales: | Ohmes, Justus, Comdühr, Sara, Akbarzadeh, Reza, Riemekasten, Gabriela, Humrich, Jens Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650673/ https://www.ncbi.nlm.nih.gov/pubmed/36389689 http://dx.doi.org/10.3389/fimmu.2022.1007078 |
Ejemplares similares
-
Regulatory T cells inhibit autoantigen-specific CD4(+) T cell responses in lupus-prone NZB/W F1 mice
por: Rosenberger, Stefan, et al.
Publicado: (2023) -
When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis
por: Akbarzadeh, Reza, et al.
Publicado: (2023) -
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases
por: Graßhoff, Hanna, et al.
Publicado: (2021) -
Natural Treg and role of IL-2 in lupus
por: Riemekasten, Gabriela, et al.
Publicado: (2011) -
CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
por: Weigert, Olivia, et al.
Publicado: (2013)